Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Learn which blue chip coins to buy in 2026 and why they stand out in terms of reliability, liquidity, and long-term potential.
25,977 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Veteran CBS News analyst Jill Schlesinger is launching a new podcast to help listeners make smarter money decisions a...
Bitcoin sits at a critical crossroads as institutional demand accelerates for spot ETFs, tokenized securities, and co...
AI isn’t just taking jobs; it could reshape how Social Security is funded and what it means for investors in 2026. Th...
The final BEA report for 2025 shows stronger-than-expected growth across consumption and investment, setting a positi...
Shake Shack delivered a blowout Q4, where earnings beat expectations by a wide margin and revenue surged. The company...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
A new study ties ethical leadership to stronger profits, showing that business, nice guys finish when firms prioritiz...
The standard Medicare Part B premium surpassed $200 per month in 2026, up $17.90 from 2025. With COLA growth lagging ...
A disciplined value-focused approach has outpaced the S&P 500 for almost five years, signaling a leadership shift as ...
A two-year income lookback in Medicare pricing can surprise retirees after asset sales. This report explains how the ...
A coalition of chefs and tech-minded entrepreneurs is moving to scale Japan-inspired fine dining from Arkansas to the...